Follow
Shivakant
Shivakant
Research Scientist
Verified email at beaumont.org
Title
Cited by
Cited by
Year
Novel molecular mechanisms of antitumor action of dichloroacetate against T cell lymphoma: Implication of altered glucose metabolism, pH homeostasis and cell survival regulation
A Kumar, S Kant, SM Singh
Chemico-biological interactions 199 (1), 29-37, 2012
1012012
Enhanced fatty acid oxidation provides glioblastoma cells metabolic plasticity to accommodate to its dynamic nutrient microenvironment
S Kant, P Kesarwani, A Prabhu, SF Graham, KL Buelow, I Nakano, ...
Cell Death & Disease 11 (4), 253, 2020
822020
Tryptophan metabolism contributes to radiation-induced immune checkpoint reactivation in glioblastoma
P Kesarwani, A Prabhu, S Kant, P Kumar, SF Graham, KL Buelow, ...
Clinical Cancer Research 24 (15), 3632-3643, 2018
562018
Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and …
A Kumar, S Kant, SM Singh
Toxicology and applied pharmacology 273 (1), 196-208, 2013
562013
Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and …
S Kant, A Kumar, SM Singh
Biochimica et Biophysica Acta (BBA)-General Subjects 1840 (1), 294-302, 2014
532014
The interplay between metabolic remodeling and immune regulation in glioblastoma
P Kesarwani, S Kant, A Prabhu, P Chinnaiyan
Neuro-oncology 19 (10), 1308-1315, 2017
522017
Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: role of cell survival regulatory molecules
S Kant, A Kumar, SM Singh
Biochimica et Biophysica Acta (BBA)-General Subjects 1820 (11), 1764-1773, 2012
462012
Metabolic remodeling contributes towards an immune-suppressive phenotype in glioblastoma
P Kesarwani, A Prabhu, S Kant, P Chinnaiyan
Cancer Immunology, Immunotherapy 68, 1107-1120, 2019
422019
Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis
A Prabhu, P Kesarwani, S Kant, SF Graham, P Chinnaiyan
Neuro-oncology 19 (12), 1599-1606, 2017
312017
Inhibition of colony-stimulating factor-1 receptor enhances the efficacy of radiotherapy and reduces immune suppression in glioblastoma
MF Almahariq, TJ Quinn, P Kesarwani, S Kant, CR Miller, P Chinnaiyan
In Vivo 35 (1), 119-129, 2021
302021
α-Cyano-4-hydroxycinnamate induces apoptosis in Dalton’s lymphoma cells: role of altered cell survival-regulatory mechanisms
A Kumar, S Kant, SM Singh
Anti-Cancer Drugs 24 (2), 158-171, 2013
292013
Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma
AH Prabhu, S Kant, P Kesarwani, K Ahmed, P Forsyth, I Nakano, ...
Neuro-oncology 21 (3), 337-347, 2019
272019
Targeting monocarboxylate transporter by α-cyano-4-hydroxycinnamate modulates apoptosis and cisplatin resistance of Colo205 cells: implication of altered cell survival regulation
A Kumar, S Kant, SM Singh
Apoptosis 18, 1574-1585, 2013
262013
Myelopotentiating effect of curcumin in tumor-bearing host: role of bone marrow resident macrophages
NK Vishvakarma, A Kumar, A Kumar, S Kant, AC Bharti, SM Singh
Toxicology and applied pharmacology 263 (1), 111-121, 2012
222012
Perhexiline demonstrates FYN-mediated antitumor activity in glioblastoma
S Kant, P Kesarwani, AR Guastella, P Kumar, SF Graham, KL Buelow, ...
Molecular cancer therapeutics 19 (7), 1415-1422, 2020
182020
Myelopoietic efficacy of orlistat in murine hosts bearing T cell lymphoma: Implication in macrophage differentiation and activation
S Kant, A Kumar, SM Singh
PLoS One 8 (12), e82396, 2013
182013
Quinolinate promotes macrophage-induced immune tolerance in glioblastoma through the NMDAR/PPARγ signaling axis
P Kesarwani, S Kant, Y Zhao, A Prabhu, KL Buelow, CR Miller, ...
Nature Communications 14 (1), 1459, 2023
102023
Bicarbonate transport inhibitor SITS modulates pH homeostasis triggering apoptosis of Dalton’s lymphoma: implication of novel molecular mechanisms
S Kant, A Kumar, SM Singh
Molecular and cellular biochemistry 397, 167-178, 2014
92014
The influence of the ketogenic diet on the Immune tolerant microenvironment in glioblastoma
P Kesarwani, S Kant, Y Zhao, CR Miller, P Chinnaiyan
Cancers 14 (22), 5550, 2022
72022
CBMT-28. FATTY ACID OXIDATION PROVIDES METABOLIC PLASTICITY TO MAINTAIN GROWTH IN THE DYNAMIC MICROENVIRONMENT OF GLIOBLASTOMA
S Kant, P Kesarwani, A Prabhu, S Graham, K Buelow, I Nakano, ...
Neuro-Oncology 21 (Suppl 6), vi39, 2019
12019
The system can't perform the operation now. Try again later.
Articles 1–20